The pharma industry in India continues to grow rapidly and as it does the regulatory environment continues to shift. With over thirty years experience in pharma Tapan Ray has a broad overview of ...

This article is authored by Ranjit Barshikar, CEO, QbD International, CGMP Consulting, United Nations Adviser.

Union Minister of State for Health and Family Welfare, Anupriya Patel, delivered the keynote address at the 15th ...

The three-day conference will address crucial topics related to pharmaceutical regulation, impurity assessment, sustainability, and future governance of the IMWP.

Additional funding for biotechnology, AI-driven pharma research, and bio-manufacturing infrastructure will help position India as a leader in advanced pharmaceutical manufacturing. It is pertinent ...

India's J B Chemicals & Pharmaceuticals reported a bigger third-quarter profit on Tuesday, helped by sustained domestic demand for its drugs for chronic and acute conditions.

Indian drugmaker Alembic Pharmaceuticals reported a lower third-quarter profit on Monday, weighed down by weak local sales of its drugs that treat acute illnesses.

India may become a destination in the US's new "friend-shoring" policy for the pharmaceutical industry, reported Hinrich Foundation. The term friend-shoring is used for the act of moving supply ...

As India Inc is eagerly awaiting the simplification ... It is expected that the pharmaceutical and healthcare industry will remain at the centre stage of the government’s growth agenda.